Safety of postdischarge extended venous thromboembolism prophylaxis after hepatopancreatobiliary surgery

被引:0
|
作者
Cramer, Christopher L. [1 ,2 ]
Cunningham, Michaela [1 ,2 ]
Zhang, Ashley M. [3 ]
Pambianchi, Hannah L. [3 ]
James, Amber L. [3 ]
Lattimore, Courtney M. [1 ,2 ]
Cummins, Kaelyn C. [1 ,2 ]
Turkheimer, Lena M. [1 ,2 ]
Turrentine, Florence E. [1 ,2 ]
Zaydfudim, Victor M. [1 ,2 ]
机构
[1] Univ Virginia, Dept Surg, Div Surg Oncol, Charlottesville, VA 22904 USA
[2] Univ Virginia, Surg Outcomes Res Ctr, Charlottesville, VA 22904 USA
[3] Univ Virginia, Sch Med, Charlottesville, VA USA
关键词
Extended VTE prophylaxis; Hepatobiliary surgery; HPB surgery; INTERNATIONAL STUDY-GROUP; POSTPANCREATECTOMY HEMORRHAGE; MAJOR SURGERY; LIVER SURGERY; RISK-FACTORS; COMPLICATIONS; THROMBOPROPHYLAXIS; IMPLEMENTATION; DEFINITION; ENOXAPARIN;
D O I
10.1016/j.gassur.2023.11.020
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: The risk of venous thromboembolism (VTE) after hepatopancreatobiliary (HPB) surgery is high. Extended postdischarge prophylaxis in this patient population has been controversial. This study aimed to examine the safety of postdischarge extended VTE prophylaxis in patients at high risk of VTE events after HPB surgery. Methods: Adult patients risk stratified as very high risk of VTE who underwent HPB operations between 2014 and 2020 at a quaternary care center were included. Patients were matched 1:2 extended VTE prophylaxis to the control group (patients who did not receive extended prophylaxis). Analyses compared the proportions of adverse bleeding events between groups. Results: A total of 307 patients were included: 103 in the extended prophylaxis group and 204 in the matched control group. Demographics were similar between groups. More patients in the extended VTE prophylaxis group had a history of VTE (9% vs 3%; P = .045). There was no difference in bleeding events between the extended VTE prophylaxis and the control group (6% vs 2%; P = .091). Of the 6 patients with bleeding events in the VTE prophylaxis group, 5 had gastrointestinal (GI) bleeding, and 1 had hemarthrosis. Of the 4 patients with bleeding events in the control group, 1 had intra-abdominal bleeding, 2 had GI bleeding, and 1 had intra-abdominal and GI bleeding. Conclusion: Patients discharged with extended VTE prophylaxis after HPB surgery did not experience more adverse bleeding events compared with a matched control group. Routine postdischarge extended VTE prophylaxis is safe in patients at high risk of postoperative VTE after HPB surgery. (c) 2023 Society for Surgery of the Alimentary Tract. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:115 / 120
页数:6
相关论文
共 50 条
  • [31] Extended prophylaxis of venous thromboembolism with idraparinux
    Buller, Harry R.
    Cohen, Ander T.
    Davidson, Bruce
    Decousus, Herve
    Gallus, Alex S.
    Gent, Michael
    Pillion, Gerard
    Piovella, Franco
    Prins, Martin H.
    Raskob, Gary E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (11): : 1105 - 1112
  • [32] Post-Discharge Venous Thromboembolism After Cancer Surgery Extending the Case for Extended Prophylaxis
    Merkow, Ryan P.
    Bilimoria, Karl Y.
    McCarter, Martin D.
    Cohen, Mark E.
    Barnett, Carlton C.
    Raval, Mehul V.
    Caprini, Joseph A.
    Gordon, Howard S.
    Ko, Clifford Y.
    Bentrem, David J.
    ANNALS OF SURGERY, 2011, 254 (01) : 131 - 137
  • [33] Avoiding the needle: apixaban for extended venous thromboembolism prophylaxis after major gynecologic cancer surgery
    Mcginnis, Justin M.
    Stewart, Kimberly
    Jafari, Helia
    Santos, Jennifer
    Pattillo, Jane
    Lee, Agnes
    Kwon, Janice
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A83 - A83
  • [34] EXTENDED POSTDISCHARGE VENOUS THROMBOEMBOLISM PROPHYLAXIS AMONGST MEMBERS OF THE AMERICAN SOCIETY OF COLON AND RECTAL SURGEONS.
    Sheldon, H.
    Alva, S.
    Chinn, B.
    Notaro, J.
    Wilkins, K.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E345 - E345
  • [35] Validation of Predictive Scores for Venous Thromboembolism after Hepatopancreatobiliary Surgery Using Claims Data
    Vyas, Vanessa K.
    Fuccello, Ashlynn
    Schootman, Mario
    Mavros, Michail
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S292 - S292
  • [36] Low-Dose Rivaroxaban as Extended Prophylaxis Reduces Postdischarge Venous Thromboembolism in Patients With Malignancy and IBD
    Ogilvie Jr, James W.
    Khan, Mariam T.
    Hayakawa, Emiko
    Parker, Jessica
    Luchtefeld, Martin A.
    DISEASES OF THE COLON & RECTUM, 2024, 67 (03) : 457 - 465
  • [37] The role of extended venous thromboembolism prophylaxis following urologic pelvic surgery
    Sagalovich, Daniel
    Say, Rollin
    Kaouk, Jihad
    Mehrazin, Reza
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (03) : 83 - 87
  • [38] Incidence of Venous Thromboembolism in Patients With and Without Extended Venous Thromboembolism Prophylaxis
    Torres Garcia, Antonio Jose
    Cano Valderrama, Oscar
    OBESITY SURGERY, 2010, 20 (06) : 819 - 819
  • [39] Safety and Effectiveness of Enoxaparin as Venous Thromboembolism Prophylaxis after Gastric Cancer Surgery in Japanese Patients
    Yanagita, Takeshi
    Kusanagi, Hiroshi
    AMERICAN SURGEON, 2016, 82 (12) : 1232 - 1237
  • [40] Efficacy and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis after major abdominal and pelvic surgery: an international, prospective cohort study
    Sgro, A.
    BRITISH JOURNAL OF SURGERY, 2023, 110 : III24 - III24